Ilmarinen Mutual Pension Insurance Co Invests $1.97 Million in The Clorox Company $CLX

Ilmarinen Mutual Pension Insurance Co purchased a new position in The Clorox Company (NYSE:CLX) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 19,500 shares of the company’s stock, valued at approximately $1,966,000.

A number of other institutional investors have also recently added to or reduced their stakes in CLX. State Street Corp increased its position in Clorox by 3.5% in the third quarter. State Street Corp now owns 8,434,277 shares of the company’s stock worth $1,039,946,000 after buying an additional 282,794 shares during the period. Invesco Ltd. boosted its holdings in shares of Clorox by 23.1% during the third quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after acquiring an additional 750,415 shares during the period. Geode Capital Management LLC grew its position in shares of Clorox by 0.3% during the fourth quarter. Geode Capital Management LLC now owns 3,172,233 shares of the company’s stock worth $318,613,000 after acquiring an additional 10,060 shares during the last quarter. Van ECK Associates Corp increased its holdings in shares of Clorox by 93.9% in the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock worth $334,139,000 after acquiring an additional 1,312,471 shares during the period. Finally, Two Sigma Investments LP increased its holdings in shares of Clorox by 33.8% in the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock worth $214,564,000 after acquiring an additional 439,797 shares during the period. 78.53% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on CLX shares. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $91.00 target price on shares of Clorox in a research note on Friday, May 1st. Zacks Research downgraded Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. BNP Paribas Exane decreased their price objective on Clorox from $128.00 to $97.00 and set a “neutral” rating for the company in a report on Tuesday, May 12th. The Goldman Sachs Group reaffirmed a “sell” rating and set a $83.00 target price on shares of Clorox in a research note on Friday, May 1st. Finally, Weiss Ratings upgraded Clorox from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Monday, April 13th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Reduce” and an average target price of $103.40.

Insider Activity

In other news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction dated Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the transaction, the director owned 18,000 shares in the company, valued at $1,544,760. This trade represents a 38.46% increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 0.63% of the company’s stock.

Clorox Stock Down 6.5%

CLX stock opened at $89.98 on Friday. The firm’s 50-day moving average is $98.46 and its two-hundred day moving average is $105.81. The company has a market capitalization of $10.88 billion, a price-to-earnings ratio of 14.61, a price-to-earnings-growth ratio of 0.50 and a beta of 0.59. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $132.03. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The business had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. During the same quarter last year, the business earned $1.45 earnings per share. The business’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. On average, analysts forecast that The Clorox Company will post 5.61 earnings per share for the current fiscal year.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.